Recent progress in work on PGD2 antagonists for drugs targeting allergic diseases

被引：25

作者：

Mitsumori, S ^{[1
]}

机构：

[1] Shionogi & Co Ltd, Shionogi Res Labs, Fukushima Ku, Osaka 5530002, Japan

来源：

CURRENT PHARMACEUTICAL DESIGN | 2004年 / 10卷 / 28期

关键词：

PGD(2); CRTH2; BWA868C; S-5751; ramatroban; indometahcin; eosinophil;

D O I：

10.2174/1381612043382864

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Prostaglandin (PG) D-2, the major cyclooxygenase metabolite generated from immunologically stimulated mast cells, is thought to contribute to the pathogenesis of allergic diseases due to its various inflammatory effects. However, the lack of PGD(2) (DP) receptor antagonists has limited the study of its essential roles in the disease state. Recent discoveries of several DP receptor antagonists, the development of the mutant mouse and the discovery of a second PGD(2) receptor, CRTH2 (chemoattractant receptor-homologousmolecule expressed on Th2 cells) receptor, have revealed the crucial roles of PGD(2) and CRTH2 receptors in allergic disorders. This review presents biological evidence that PGD(2) plays an essential role in allergy disorders and discusses the therapeutic possibilities of recently reported PGD(2) antagonists.

引用

页码：3533 / 3538

页数：6

共 42 条

[1]

Arimura A, 2001, J PHARMACOL EXP THER, V298, P411

[2]

BAHRAM R, 1993, J MED CHEM, V36, P243

[3] Synthesis of hexahydrocyclopentimidazol-2-(1H)-one derivatives displaying selective DP-receptor agonist properties [J].

Barraclough, P ;

Bolofo, ML ;

Giles, H ;

Gillam, J ;

Harris, CJ ;

Kelly, MG ;

Leff, P ;

McNeill, A ;

Robertson, AD ;

Stepney, RJ ;

Whittle, BJR .

BIOORGANIC & MEDICINAL CHEMISTRY, 1996, 4 (01) :81-90

[4] SYNTHESIS AND INHIBITORY ACTIVITY ON PLATELET-AGGREGATION OF 13'-AZA AND OTHER OMEGA-CHAIN MODIFIED BW245C ANALOGS [J].

BARRACLOUGH, P ;

BROCKWELL, M ;

CALDWELL, AG ;

DEMAINE, DA ;

HARRIS, CJ ;

KING, WR ;

STEPNEY, RJ ;

WHARTON, CJ ;

WHITTLE, BJR .

ARCHIV DER PHARMAZIE, 1994, 327 (05) :307-317

[5] MOLECULAR-CLONING AND CHARACTERIZATION OF THE HUMAN PROSTANOID DP RECEPTOR [J].

BOIE, Y ;

SAWYER, N ;

SLIPETZ, DM ;

METTERS, KM ;

ABRAMOVITZ, M .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (32) :18910-18916

[6] HYDANTOIN PROSTAGLANDIN ANALOGS, POTENT AND SELECTIVE INHIBITORS OF PLATELET-AGGREGATION [J].

CALDWELL, AG ;

HARRIS, CJ ;

STEPNEY, R ;

WHITTAKER, N .

JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1979, (13) :561-562

[7]

CALDWELL AG, 1984, Patent No. 126849

[8]

CHALOTTA L, 1993, BIOORG MED CHEM LETT, V3, P241

[9] Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: pharmacological characterization using agonists and antagonists [J].

Crider, JY ;

Griffin, BW ;

Sharif, NA .

BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (01) :204-210

[10] PHYSIOLOGICAL-RESPONSES TO INTRANASAL DOSE-RESPONSE CHALLENGES WITH HISTAMINE, METHACHOLINE, BRADYKININ, AND PROSTAGLANDIN IN ADULT VOLUNTEERS WITH AND WITHOUT NASAL ALLERGY [J].

DOYLE, WJ ;

BOEHM, S ;

SKONER, DP .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1990, 86 (06) :924-935

← 1 2 3 4 5 →